Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility, and ...

Shares of Immunic (NASDAQ:IMUX) lost ~22% in the premarket on Wednesday after the immunology-focused biotech posted data from a Phase 2 trial for its lead candidate, vidofludimus calcium, targeted ...

Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system. This impairs the transmission of signals between the brain and body and can ...

According to a 2022 study, the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost of $63.3 billion; indirect and nonmedical ...

The corneal nerve parameters of patients with multiple sclerosis could be used to evaluate and monitor the stages of the disease, according to a poster presented at the Women in Ophthalmology ...

Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system. This impairs the transmission of signals between the brain and body and can ...